Total Payments
$19,017
2024 Payments
$129.27
Companies
20
Transactions
136
Medicare Patients
6,354
Medicare Billing
$427,900
Payment Breakdown by Category
Consulting$11,900 (62.6%)
Other$2,700 (14.2%)
Food & Beverage$2,584 (13.6%)
Travel$1,820 (9.6%)
Education$13.89 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $11,900 | 1 | 62.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,700 | 1 | 14.2% |
| Food and Beverage | $2,584 | 123 | 13.6% |
| Travel and Lodging | $1,820 | 10 | 9.6% |
| Education | $13.89 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $16,700 | 18 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $481.16 | 39 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $397.20 | 21 | $0 (2024) |
| AltaThera Pharmaceuticals LLC | $330.20 | 1 | $0 (2023) |
| Boston Scientific Corporation | $257.08 | 7 | $0 (2024) |
| Amgen Inc. | $199.95 | 12 | $0 (2023) |
| PFIZER INC. | $153.17 | 11 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $123.31 | 8 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $77.95 | 1 | $0 (2022) |
| Merck Sharp & Dohme LLC | $56.84 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $129.27 | 6 | Novartis Pharmaceuticals Corporation ($42.40) |
| 2023 | $749.67 | 20 | AltaThera Pharmaceuticals LLC ($330.20) |
| 2022 | $428.06 | 23 | Novartis Pharmaceuticals Corporation ($141.32) |
| 2021 | $325.21 | 29 | Janssen Pharmaceuticals, Inc ($190.61) |
| 2020 | $60.88 | 4 | Janssen Pharmaceuticals, Inc ($60.88) |
| 2019 | $21.38 | 2 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($21.38) |
| 2018 | $188.81 | 5 | Abbott Laboratories ($142.98) |
| 2017 | $17,114 | 47 | Abbott Laboratories ($16,528) |
All Payment Transactions
136 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/09/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/13/2024 | Boston Scientific Corporation | VIGILANT X4 CRT-D (Device) | Food and Beverage | In-kind items and services | $31.64 | General |
| Category: VIGILANT_CRM | ||||||
| 03/06/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/16/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Not Applicable | ||||||
| 01/11/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/06/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/16/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Cardiology | ||||||
| 11/14/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/09/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/22/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2023 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $88.94 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 09/12/2023 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $31.25 | General |
| Category: WATCHMAN_IC | ||||||
| 09/12/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Cardiology | ||||||
| 08/23/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Cardiology | ||||||
| 06/20/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.24 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/06/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Cardiology | ||||||
| 05/18/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/11/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.33 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/25/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/20/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/24/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Cardiology | ||||||
| 03/15/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/18/2023 | AltaThera Pharmaceuticals LLC | Sotalol Hydrochloride (Drug) | Food and Beverage | Cash or cash equivalent | $330.20 | General |
| Category: Cardiovascular | ||||||
| 02/09/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,431 | 1,869 | $533,512 | $97,413 |
| 2022 | 15 | 1,725 | 2,289 | $681,890 | $108,604 |
| 2021 | 17 | 1,671 | 2,294 | $677,414 | $111,811 |
| 2020 | 17 | 1,527 | 2,327 | $590,462 | $110,072 |
Total Patients
6,354
Total Services
8,779
Medicare Billing
$427,900
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 127 | 226 | $124,300 | $32,967 | 26.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 140 | 218 | $90,719 | $21,096 | 23.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 52 | 105 | $31,500 | $10,421 | 33.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 159 | 163 | $62,755 | $9,285 | 14.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 57 | 58 | $46,400 | $8,110 | 17.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 515 | 677 | $48,744 | $4,534 | 9.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 19 | 19 | $14,421 | $3,273 | 22.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 227 | 265 | $40,280 | $3,063 | 7.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 22 | $6,050 | $1,477 | 24.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 21 | 21 | $50,400 | $1,297 | 2.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 13 | 13 | $5,005 | $695.16 | 13.9% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 26 | 26 | $4,264 | $464.88 | 10.9% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 26 | 26 | $4,654 | $307.32 | 6.6% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 14 | 15 | $1,740 | $233.55 | 13.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Facility | 2023 | 14 | 15 | $2,280 | $188.90 | 8.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 111 | 167 | $91,850 | $24,191 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 133 | 209 | $86,317 | $20,363 | 23.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 105 | 232 | $84,920 | $19,594 | 23.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 75 | 76 | $58,944 | $12,507 | 21.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 165 | 168 | $141,900 | $9,831 | 6.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 672 | 930 | $66,960 | $6,328 | 9.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 20 | 20 | $15,180 | $3,871 | 25.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 246 | 273 | $41,496 | $3,221 | 7.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 48 | 54 | $14,850 | $3,121 | 21.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 20 | 28 | $7,931 | $1,770 | 22.3% |
About Dr. Kristopher Young, DO
Dr. Kristopher Young, DO is a Nuclear Cardiology healthcare provider based in Pennington, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1669693875.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kristopher Young, DO has received a total of $19,017 in payments from pharmaceutical and medical device companies, with $129.27 received in 2024. These payments were reported across 136 transactions from 20 companies. The most common payment nature is "Consulting Fee" ($11,900).
As a Medicare-enrolled provider, Young has provided services to 6,354 Medicare beneficiaries, totaling 8,779 services with total Medicare billing of $427,900. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Nuclear Cardiology
- Location Pennington, NJ
- Active Since 05/02/2007
- Last Updated 04/30/2021
- Taxonomy Code 207UN0901X
- Entity Type Individual
- NPI Number 1669693875
Products in Payments
- i-STAT 1 (Device) $16,520
- XARELTO (Drug) $481.16
- Sotalol Hydrochloride (Drug) $330.20
- ENTRESTO (Drug) $309.74
- ELIQUIS (Drug) $177.78
- Merlin Connectivity and Remote (Device) $142.98
- LifeVest (Device) $123.31
- Repatha (Biological) $111.79
- WATCHMAN FLX (Device) $88.94
- LEQVIO (Drug) $87.46
- Corlanor (Drug) $74.27
- VERQUVO (Drug) $56.84
- WATCHMAN (Device) $41.20
- PRALUENT (Drug) $36.36
- LUX-Dx Insertable Cardiac Monitor (Device) $32.66
- VIGILANT X4 CRT-D (Device) $31.64
- WATCHMAN Access System (Device) $31.25
- BG Mini Plus (Device) $30.47
- MITRACLIP (Device) $28.77
- CHANTIX (Drug) $26.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.